Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a Warning Letter to Anicare Pharmaceuticals Pvt Ltd., a pharmaceutical manufacturer, on February 28, 2019. While the specific violations are not detailed in the available metadata, the letter concerns drug products under FDA jurisdiction. Without access to the full letter text or subject line details, the precise nature of the compliance issues cannot be determined, though Warning Letters typically address manufacturing, labeling, or quality control deficiencies.